<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To observe the effect of Buyanghuanwu decoction (BYHWD) on neuronal nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (nNOS) immunoreactivity after permanent focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in rats </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The rats were randomized into <z:mpath ids='MPATH_458'>normal</z:mpath> control group, <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> model groups (with <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> for 1, 4, and 10 h respectively), and corresponding <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> groups treated with BYHWD </plain></SENT>
<SENT sid="2" pm="."><plain>Focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> was produced by permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) with nylon suture inserted through the internal carotid artery </plain></SENT>
<SENT sid="3" pm="."><plain>Brain nNOS in different brain regions was assayed by SABC immunohistochemistry at different time points ranging from 1 to 10 h after occlusion </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: nNOS activity in the cerebral tissues was enhanced in the ischemic hemisphere as the time following <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> prolonged </plain></SENT>
<SENT sid="5" pm="."><plain>Pretreatment with BYHWD group significantly decreased nNOS activity to 170.80+/-21.71 and 189.20+/-18.53 in the striatum cortex 18a region and to 127.33+/-19.83, 215.20+/-38.80, and 191.20+/-22.39 in the caudate putamen, in comparison with the untreated <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> model group (244.60+/-12.44 and 363.00+/-24.82 in the striatum cortex 18a region and 138.67+/-13.99, 266.40+/-29.25, and 373.20+/-31.55 in the caudate putamen, P&lt;0.05), and this effect began to be observed in the early stage of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and gradually high-lighted as the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> time increased </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: BYHWD significantly restrains the up-regulated activity of nNOS after focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> to protect the cerebral ischemic lesion from the early stage following the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>